Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Despite limited data, polymyxin B (PB) is increasingly used clinically as the last therapeutic option for multidrug-resistant (MDR) gram-negative bacterial infections. We examined the in vitro pharmacodynamics of PB against four strains of Pseudomonas aeruginosa. Clonal relatedness of the strains wa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tam, Vincent H., Schilling, Amy N., Vo, Giao, Kabbara, Samer, Kwa, Andrea L., Wiederhold, Nathan P., Lewis, Russell E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2005
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1195418/
https://ncbi.nlm.nih.gov/pubmed/16127031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.9.3624-3630.2005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak